Max Healthcare Institute Limited announced that its Nomination and Remuneration Committee has approved the allotment of 42,266 equity shares to eligible employees under the company's Employee Stock Option Scheme 2022. The decision was made during the committee meeting held on March 17, 2026.

Equity Share Allotment Details

The allotted equity shares are part of the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022, which complies with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The shares were issued consequent to the exercise of vested stock options by eligible employees.

Impact on Share Capital

The allotment has resulted in an increase in the company's paid-up equity share capital, reflecting the successful implementation of the employee stock option scheme.

Share Characteristics and Listing

The newly allotted equity shares are identical in all respects to the existing equity shares of the company. The shares have been issued in dematerialized form with distinctive numbers ranging from 97,30,92,776 to 97,31,35,041. The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited.

Committee Meeting and Compliance

The Nomination and Remuneration Committee meeting that approved this allotment commenced at 9:05 am IST and concluded at 9:40 am IST on March 17, 2026. The company has disclosed this information in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The allotment is not considered material in nature for the company under the applicable regulations.

Max Healthcare Institute Limited has informed the stock exchanges about its senior management's participation in an upcoming investor conference. The company's Chairman and Managing Director will represent the organization at the J.P. Morgan India Forum 2026.

Conference Details

The investor conference is scheduled to take place over two days, providing opportunities for both individual and group interactions with the investment community.

Regulatory Compliance

The announcement was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Max Healthcare Institute has emphasized its commitment to transparency by stating that no unpublished price sensitive information will be shared during the investor interactions.

Important Considerations

The company has noted that the conference schedule remains subject to potential changes due to exigencies on the part of either the investors or the company. This flexibility ensures that the meetings can be adjusted as needed while maintaining the overall framework of the forum.

The disclosure has been made available on the company's official website at www.maxhealthcare.in , ensuring broader accessibility for stakeholders and investors who wish to stay informed about the company's investor engagement activities.